| 刊名 | Medicinal Plant |
| 作者 | Yuehai MA, Qingbatu |
| 作者单位 | 1.Affiliated Hospital of Inner Mongolia Minzu University, Tongliao 028000, China; 2.Inner Mongolia Minzu University, Tongliao 028000, China |
| DOI | DOI:10.19600/j.cnki.issn2152-3924.2026.02.013 |
| 年份 | 2026 |
| 刊期 | 2 |
| 页码 | 52-54 |
| 关键词 | Professor Qingbatu, Chronic cholecystitis, Academic thought, Syndrome differentiation and treatment, Mongolian medicine |
| 摘要 | Professor Qingbatu, an inheritor of distinguished academic expertise in traditional Chinese and Mongolian medicine in China, posits that chronic cholecystitis corresponds to the condition known as “blood-Xila fever” in Mongolian medicine, primarily resulting from an imbalance of Badagan-Xila. He advocates a treatment approach centered on the stomach, emphasizing the protection of stomach fire, while concurrently incorporating methods to clear Xila and regulate liver and gallbladder function. Clinical staging and syndrome differentiation should be systematically conducted, with the effective utilization of Mongolian patent medicines such as Tonglaga-5, Zhagan Beng’a-18, and the Digeda series. A literature review encompassing 884 patients across eight clinical studies indicates that Mongolian medicine offers advantages in treating chronic cholecystitis, particularly in symptom improvement and recurrence rate reduction. Furthermore, the medications employed align closely with the clinical practices of Professor Qingbatu. Professor Qingbatu’s academic approach, which emphasizes “gastric protection alongside the elimination of pathogenic factors”, is distinctive and holds substantial clinical significance. |
